The observed increase in PON1 activity levels would in this manner reflect a defence mechanism to prevent further hepatometabolic manifestations that lead to the advancement of obesity to NAFLD/NASH. This evidence concerns the gene PON1 and metabolic dysfunction-associated steatohepatitis.